Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05689502 · ClinicalTrials.gov registry record · NA

intenSive UpPer Extremity Recovery Program for Chronic Stroke (SUPER)

A NA study of Chronic Stroke, sponsored by The University of Texas Health Science Center, Houston.

Active
Registry status
NA
Development phase
9
Enrollment target
1
Study location

NCT05689502 is a NA study of Chronic Stroke that is active but no longer recruiting, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 9 participants, below the 43-participant average among 20 other Chronic Stroke trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05689502, a NA study of Chronic Stroke, is active but no longer recruiting, sponsored by The University of Texas Health Science Center, Houston.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
9 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to Investigate the feasibility of a high-quality, high-dose, high-intensity upper extremity therapy program and to assess the treatment effects of a high-quality, high-dose, high-intensity upper extremity therapy program on functional outcomes, motor impairment, and quality of life

Conditions Studied

Interventions

  • DEVICE Treatment

Study Locations (1)

Texas

  • The University of Texas Health Science Center at Houston - Houston

Trial Details

FieldValue
Enrollment Target 9 participants
Start Date 2023-03-20
Est. Completion 2026-12-31
Phase NA

What the Registry Record Tells You About NCT05689502

The ClinicalTrials.gov registry entry for NCT05689502 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 43-participant average among 20 other Chronic Stroke trials with a reported enrollment target (79% lower). The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Chronic Stroke appearing as the primary indexed condition, and to 1 intervention - of which Treatment is the first listed.

NCT05689502 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT05689502 about?

NCT05689502 is a clinical study titled "intenSive UpPer Extremity Recovery Program for Chronic Stroke (SUPER)". The purpose of this study is to Investigate the feasibility of a high-quality, high-dose, high-intensity upper extremity therapy program and to assess the treatment effects of a high-quality, high-dose, high-intensity upper extremity therapy program on functional outcomes, motor impairment, and qual...

What is the current status of trial NCT05689502?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 9 participants. The study started on 2023-03-20. Estimated completion is 2026-12-31.

What conditions does trial NCT05689502 study?

This clinical trial studies the following conditions: Chronic Stroke.

What interventions are being tested in trial NCT05689502?

The interventions under investigation include: Treatment (DEVICE).

Who is sponsoring clinical trial NCT05689502?

This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05689502 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.